Glucocorticoid chronotherapy in rheumatoid arthritis

被引：27

作者：

Bijlsma, Johannes W. J. ^{[1
]}

Jacobs, Johannes W. G. ^{[1
]}

机构：

[1] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, NL-3508 GA Utrecht, Netherlands

来源：

LANCET | 2008年 / 371卷 / 9608期

关键词：

D O I：

10.1016/S0140-6736(08)60114-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：183 / 184

页数：2

共 15 条

[1] The timing of glucocorticoid administration in rheumatoid arthritis [J].

Arvidson, NG ;

Gudbjornsson, B ;

Larsson, A ;

Hallgren, R .

ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (01) :27-31

[2] Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility [J].

Bakker, M. F. ;

Jacobs, J. W. G. ;

Verstappen, S. M. M. ;

Bijlsma, J. W. J. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 :56-60

[3] Optimal use of methotrexate: the advantages of tight control [J].

Bijlsma, Johannes W. J. ;

Weinblatt, Michael E. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (11) :1409-1410

[4] Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial [J].

Buttgereit, Frank ;

Doering, Gisela ;

Schaeffler, Achim ;

Witte, Stephan ;

Sierakowski, Stanislaw ;

Gromnica-Ihle, Erika ;

Jeka, Slawomir ;

Krueger, Klaus ;

Szechinski, Jacek ;

Alten, Rieke .

LANCET, 2008, 371 (9608) :205-214

[5] EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) [J].

Combe, B. ;

Landewe, R. ;

Lukas, C. ;

Bolosiu, H. D. ;

Breedveld, F. ;

Dougados, M. ;

Emery, P. ;

Ferraccioli, G. ;

Hazes, J. M. W. ;

Klareskog, L. ;

Machold, K. ;

Martin-Mola, E. ;

Nielsen, H. ;

Silman, A. ;

Smolen, J. ;

Yazici, H. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (01) :34-45

[6] Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis [J].

Crofford, LJ ;

Kalogeras, KT ;

Mastorakos, G ;

Magiakou, MA ;

Wells, J ;

Kanik, KS ;

Gold, PW ;

Chrousos, GP ;

Wilder, RL .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :1279-1283

[7] Safety of low dose glucocorticoid treatment in rheumatoid arthritis:: published evidence and prospective trial data [J].

Da Silva, JAP ;

Jacobs, JWG ;

Kirwan, JR ;

Boers, M ;

Saag, KG ;

Inês, LBS ;

de Koning, EJP ;

Buttgereit, F ;

Cutolo, M ;

Capell, H ;

Rau, R ;

Bijlsma, JWJ .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (03) :285-293

[8] EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases [J].

Hoes, J. N. ;

Jacobs, J. W. G. ;

Boers, M. ;

Boumpas, D. ;

Buttgereit, F. ;

Caeyers, N. ;

Choy, E. H. ;

Cutolo, M. ;

Da Silva, J. A. P. ;

Esselens, G. ;

Guillevin, L. ;

Hafstrom, I. ;

Kirwan, J. R. ;

Rovensky, J. ;

Russell, A. ;

Saag, K. G. ;

Svensson, B. ;

Westhovens, R. ;

Zeidler, H. ;

Bijlsma, J. W. J. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (12) :1560-1567

[9] Followup radiographic data on patients with rheumatoid arthritis who participated in a two-year trial of prednisone therapy or placebo [J].

Jacobs, JWG ;

van Everdingen, AA ;

Verstappen, SMM ;

Bijlsma, JWJ .

ARTHRITIS AND RHEUMATISM, 2006, 54 (05) :1422-1428

[10]

Kirwan JR, 2007, COCHRANE DB SYST REV, V1

← 1 2 →